| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.08 | 0.05 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.089 | 0.06 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.033 | 0.5 |